Holen Sie sich die Stockscreener-App
19.38
0.51%
-0.10
Schlusskurs vom Vortag:
$19.48
Offen:
$19.6
24-Stunden-Volumen:
5,801
Relative Volume:
0.16
Marktkapitalisierung:
$1.00B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.28M
KGV:
-9.7109
EPS:
-1.9957
Netto-Cashflow:
$-57.45M
1W Leistung:
+0.52%
1M Leistung:
-2.56%
6M Leistung:
+14.27%
1J Leistung:
+65.64%
1-Tages-Spanne:
$19.27
$19.60
1-Wochen-Bereich:
$19.16
$19.75
52-Wochen-Spanne:
$10.79
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Firmenname
Oculis Holding Ag
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.38 | 1.00B | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
443.98 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
526.01 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
319.45 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.99 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-10-05 | Eingeleitet | Stifel | Buy |
| 2023-06-14 | Eingeleitet | BofA Securities | Buy |
| 2023-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-06-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-10 | Eingeleitet | Pareto | Buy |
| 2023-04-28 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Oculis Holding AG (NASDAQ:OCS) Holdings Raised by Bank of America Corp DE - Defense World
Leerink Partnrs Forecasts Oculis’ Q2 Earnings (NASDAQ:OCS) - Defense World
When the Price of (OCS) Talks, People Listen - news.stocktradersdaily.com
Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals - TipRanks
Leerink Partners raises Oculis stock price target to $50 from $22 - Investing.com
Oculis Holding AG Reports Outcomes of 2025 Annual General Meeting and Shareholder Approvals - Nasdaq
Oculis Publishes Results of 2025 Annual General Meeting - The Manila Times
Citadel Advisors LLC Buys Shares of 22,911 Oculis Holding AG (NASDAQ:OCS) - Defense World
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com
Oculis to Participate in Upcoming June Investor Conferences - InvisionMag.com
Oculis Holding AG Announces Participation in Upcoming Investor Conferences in June 2025 - Nasdaq
Trend Tracker for (OCS) - news.stocktradersdaily.com
Trend Tracker for (OCSAW) - news.stocktradersdaily.com
HC Wainwright Weighs in on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World
HC Wainwright Estimates Oculis’ Q2 Earnings (NASDAQ:OCS) - Defense World
Oculis (NASDAQ:OCS) Sees Large Volume Increase on Analyst Upgrade - Defense World
Oculis (NASDAQ:OCS) Price Target Raised to $33.00 - Defense World
Oculis Publishes Invitation to the Annual General Meeting - The Manila Times
Oculis Holding AG (OCS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Oculis Announces 2025 Annual General Meeting Details - TipRanks
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Oculis Reports Q1 2025 Financial Results and Provides Company Update - The Manila Times
Oculis Holding AG Reports Strong Q1 Progress - TipRanks
Learn to Evaluate (OCSAW) using the Charts - news.stocktradersdaily.com
Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline - MSN
Oculis Holding AG reports results for the quarter ended March 31Earnings Summary - TradingView
Oculis Holding AG Reports Q1 2025 Financial Results - TipRanks
Oculis to Present at Upcoming May Investor Conferences - EIN News
REG-Oculis to Present at Upcoming May Investor Conferences - TradingView
Long Term Trading Analysis for (OCS) - news.stocktradersdaily.com
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume – Still a Buy? - Defense World
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - The Manila Times
Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in 2025 - Nasdaq
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - GlobeNewswire Inc.
Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in May 2025 - Nasdaq
Oculis Updates Share Capital - The Manila Times
Long Term Trading Analysis for (OCSAW) - news.stocktradersdaily.com
(OCS) Trading Advice - news.stocktradersdaily.com
Chardan Capital Reaffirms Buy Rating for Oculis (NASDAQ:OCS) - Defense World
HC Wainwright Increases Oculis (NASDAQ:OCS) Price Target to $32.00 - Defense World
Oculis (NASDAQ:OCS) Shares Gap Up Following Analyst Upgrade - Defense World
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award - The Manila Times
Stifel maintains Buy rating, $35 target on Oculis shares By Investing.com - Investing.com South Africa
Stifel maintains Buy rating, $35 target on Oculis shares - Investing.com
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day - TipRanks
Finanzdaten der Oculis Holding Ag-Aktie (OCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.37%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):